Josie Smith
Biographic Data
| ID | 3926892 |
|---|---|
| NAME | Josie Smith |
| GIVEN NAMES | Josie |
| FAMILY NAME | Smith |
| SIGNATURE | SMITH J |
| AFFILIATIONS | Public Health Wales |
| ORCID | 0000-0002-7671-104X |
| VERIFIED | Yes |
| TOTAL WORKS | 7 |
| TOTAL CITATIONS | 38 |
| AUTHOR COUNT | 7 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2007 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 1 |
Using modelling and public health surveillance data to evidence progress towards the WHO incidence target for hepatitis C elimination in people who inject drugs - a review of complementary approaches …
Anabolic androgenic steroid use population size estimation
Harms associated with anabolic androgenic steroids (AAS) use are well-established and a public health concern. Robust estimates of the numbers using AAS are needed to inform responses, however, in the UK these are lacking. Due to the comparative rarity and associated stigma, general population surveys are problematic and data availability limits the use of indirect approaches. To address this, the Delphi method was used to refine the key paramete…
A rapid assessment of take-home naloxone provision during Covid-19 in Europe
Through programme innovation supported by public guidelines, many European THN programmes managed to ensure stable or even increased THN provision during the pandemic, despite social distancing and stay-at-home orders affecting client mobility
Factors associated with hepatitis C and HIV testing uptake among men who inject image and performance enhancing drugs
Identifying a typology of men who use anabolic androgenic steroids (AAS)
The results of this study demonstrate the need to make information about AAS accessible to the general population and to inform health service providers about variations in motivations and associated risk behaviours. Attention should also be given to ensuring existing harm minimisation services are equipped to disseminate information about safe intra-muscular injecting and ensuring needle disposal sites are accessible to the different types
The extent of and factors associated with self-reported overdose and self-reported receipt of naloxone among people who inject drugs (PWID) in England, Wales and Northern Ireland
Risk, shame and the public injector
Risk, shame and the public injector
The extent of and factors associated with self-reported overdose and self-reported receipt of naloxone among people who inject drugs (PWID) in England, Wales and Northern Ireland
Identifying a typology of men who use anabolic androgenic steroids (AAS)
The results of this study demonstrate the need to make information about AAS accessible to the general population and to inform health service providers about variations in motivations and associated risk behaviours. Attention should also be given to ensuring existing harm minimisation services are equipped to disseminate information about safe intra-muscular injecting and ensuring needle disposal sites are accessible to the different types
Factors associated with hepatitis C and HIV testing uptake among men who inject image and performance enhancing drugs
A rapid assessment of take-home naloxone provision during Covid-19 in Europe
Through programme innovation supported by public guidelines, many European THN programmes managed to ensure stable or even increased THN provision during the pandemic, despite social distancing and stay-at-home orders affecting client mobility
Anabolic androgenic steroid use population size estimation
Harms associated with anabolic androgenic steroids (AAS) use are well-established and a public health concern. Robust estimates of the numbers using AAS are needed to inform responses, however, in the UK these are lacking. Due to the comparative rarity and associated stigma, general population surveys are problematic and data availability limits the use of indirect approaches. To address this, the Delphi method was used to refine the key paramete…
Using modelling and public health surveillance data to evidence progress towards the WHO incidence target for hepatitis C elimination in people who inject drugs - a review of complementary approaches …
Medicine (6 works) · HIV, Drug Use, Sexual Risk (5 works) · Internal Medicine (4 works) · Public health (4 works) · Anabolic-Androgenic Steroids (2 works) · Anabolism (2 works) · Hepatitis C (2 works) · Hepatitis C virus (2 works) · Hepatitis C virus research (2 works) · Hormonal and reproductive studies (2 works)